FDA Removes Clinical Hold on Nomlabofusp Study for Friedreich’s Ataxia
source: pixabay.com

FDA Removes Clinical Hold on Nomlabofusp Study for Friedreich’s Ataxia

Three years after the U.S. Food and Drug Administration (FDA) first placed a full clinical hold on Larimar Therapeutics’ Phase 2 clinical study, the hold has officially been lifted. The…

Continue Reading FDA Removes Clinical Hold on Nomlabofusp Study for Friedreich’s Ataxia
Rare Community Profiles: From Afraid to Advocate: How Natalie Found Her Power After a Friedreich’s Ataxia Diagnosis
Fotocitizen / Pixabay

Rare Community Profiles: From Afraid to Advocate: How Natalie Found Her Power After a Friedreich’s Ataxia Diagnosis

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: From Afraid to Advocate: How Natalie Found Her Power After a Friedreich’s Ataxia Diagnosis
Now Approved: Skyclarys for Friedreich Ataxia
Source: https://unsplash.com/photos/ZHys6xN7sUE

Now Approved: Skyclarys for Friedreich Ataxia

  Until recently, the only therapeutic options for people with Friedreich ataxia were symptomatic and focused on symptom management: mobility aids, surgery, psychotherapy, speech therapy, heart medications, hearing and vision…

Continue Reading Now Approved: Skyclarys for Friedreich Ataxia
LX2006 Receives Rare Pediatric Disease and Orphan Drug Designations for Friedreich’s Ataxia
source: pixabay.com

LX2006 Receives Rare Pediatric Disease and Orphan Drug Designations for Friedreich’s Ataxia

The FDA grants designations, such as the Rare Pediatric Disease and Orphan Drug designations, to aid in the drug development process. Recently, LEXEO Therapeutics has received these two designations for…

Continue Reading LX2006 Receives Rare Pediatric Disease and Orphan Drug Designations for Friedreich’s Ataxia
Australian Patent Issued for Trehalose (SLS-005) for Neurodegenerative Disorders
kaboompics / Pixabay

Australian Patent Issued for Trehalose (SLS-005) for Neurodegenerative Disorders

In a press release from late January 2021, biopharmaceutical company Seelos Therapeutics, Inc. ("Seelos") announced the issuance of an Australian patent for Trehalose (SLS-005). The patent (#2019204513) centers around the…

Continue Reading Australian Patent Issued for Trehalose (SLS-005) for Neurodegenerative Disorders
How Children With Disabilities Are Excluded in Schooling During the COVID-19 Pandemic
Source: pixabay.com

How Children With Disabilities Are Excluded in Schooling During the COVID-19 Pandemic

An Australian royal commission is investigating claims that children with disabilities are being excluded from online learning, according to The Guardian. They are also looking into issues with the services…

Continue Reading How Children With Disabilities Are Excluded in Schooling During the COVID-19 Pandemic

Electrical Brain Stimulation Could Effectively Treat Neurodegenerative Ataxias

According to Newswise, new findings indicate that electrical stimulation of the spinal cord and brain may be effective in treating symptoms of a group of rare neurological movement disorders, neurodegenerative ataxias.…

Continue Reading Electrical Brain Stimulation Could Effectively Treat Neurodegenerative Ataxias
High School Senior With Friedreich’s Ataxia Fulfills Cheerleading Dream
https://pixabay.com/en/cheerleaders-football-college-nfl-654381/

High School Senior With Friedreich’s Ataxia Fulfills Cheerleading Dream

Kiara Trussell thought her dreams of being a cheerleader would never happen. This is partly because Friedreich’s ataxia has made her wheelchair bound. Friedreich’s ataxia is a progressive neurological condition.…

Continue Reading High School Senior With Friedreich’s Ataxia Fulfills Cheerleading Dream